SLV-324 Treatment of Metastatic Solid Tumors (NCT07108114)
A Phase 1 Dose-Escalation Study of SLV-324 in Subjects With Metastatic Solid Tumors
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-324 across a range of dose levels when administered to subjects with metastatic solid tumors.
Who can join: Review the eligibility criteria below.
Location: Hoag Memorial Hospital Presbyterian — Newport Beach, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Hoag Memorial Hospital Presbyterian — Newport Beach, California
- Washington University — St Louis, Missouri
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- Fox Chase Cancer Center — Philadelphia, Pennsylvania
- MD Anderson Cancer Center — Houston, Texas
- Mays Cancer Center; University of Texas Health San Antonio — Houston, Texas
- University of Washington / Fred Hutchinson Cancer Center — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (425) 894-2558
Email: hren@solvetx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Metastatic Solid Tumors
- Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) — Chicago, Illinois
- SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors — Newport Beach, California
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors — Santa Rosa, California
- The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. — Rochester, Minnesota
- A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. — Nashville, Tennessee
Explore by condition: All Metastatic Solid Tumors clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.